Longitudinal study of cervical squamous intraepithelial lesions in human immunodefidency virus (HIV)-seropositive and at-risk HIV-seronegative women

Paula Schuman, Suzanne E. Ohmit, Robert S. Klein, Ann Duerr, Susan Cu-Uvin, Denise J. Jamieson, Jean Anderson, Keerti V. Shah

Research output: Contribution to journalArticle

Abstract

We examined incidence and correlates of progression and regression of abnormal cervical cytologic test results, defined as at least low-grade squamous intraepithelial lesions (SILs), in 774 human immunodeficiency virus (HIV) - seropositive and 391 HIV-seronegative women monitored semiannually for up to 5.5 years. During follow-up, 224 (35%) HIV-seropositive women and 34 (9%) HIV-seronegative women had incident SILs detected by Pap test; 47 (7%) HIV-seropositive women developed high-grade lesions. The incidence of SILs was 11.5 cases among HIV-seropositive and 2.6 cases among HIV-seronegative women per 100 person-years of observation (rate ratio, 4.5; 95% confidence interval, 3.1-6.4; P <.001). Risk of incident SILs and likelihood of Pap test progression were increased among HIV-seropositive women with CD4+ lymphocyte counts 3 and among women with human papillomavirus (HPV) infection, with risk-ordering from low- to high-risk HPV type. SIL regression was less likely among HIV-seropositive women with higher HIV loads. No beneficial effect of highly active antiretroviral therapy was demonstrated.

Original languageEnglish (US)
Pages (from-to)128-136
Number of pages9
JournalJournal of Infectious Diseases
Volume188
Issue number1
DOIs
StatePublished - Jul 1 2003

Fingerprint

Longitudinal Studies
Viruses
Papanicolaou Test
Squamous Intraepithelial Lesions of the Cervix
Papillomavirus Infections
Incidence
Highly Active Antiretroviral Therapy
CD4 Lymphocyte Count
Observation
HIV
Confidence Intervals

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Longitudinal study of cervical squamous intraepithelial lesions in human immunodefidency virus (HIV)-seropositive and at-risk HIV-seronegative women. / Schuman, Paula; Ohmit, Suzanne E.; Klein, Robert S.; Duerr, Ann; Cu-Uvin, Susan; Jamieson, Denise J.; Anderson, Jean; Shah, Keerti V.

In: Journal of Infectious Diseases, Vol. 188, No. 1, 01.07.2003, p. 128-136.

Research output: Contribution to journalArticle

Schuman, Paula ; Ohmit, Suzanne E. ; Klein, Robert S. ; Duerr, Ann ; Cu-Uvin, Susan ; Jamieson, Denise J. ; Anderson, Jean ; Shah, Keerti V. / Longitudinal study of cervical squamous intraepithelial lesions in human immunodefidency virus (HIV)-seropositive and at-risk HIV-seronegative women. In: Journal of Infectious Diseases. 2003 ; Vol. 188, No. 1. pp. 128-136.
@article{4a0b9968244a4ef4b6b64e245e6c3b1e,
title = "Longitudinal study of cervical squamous intraepithelial lesions in human immunodefidency virus (HIV)-seropositive and at-risk HIV-seronegative women",
abstract = "We examined incidence and correlates of progression and regression of abnormal cervical cytologic test results, defined as at least low-grade squamous intraepithelial lesions (SILs), in 774 human immunodeficiency virus (HIV) - seropositive and 391 HIV-seronegative women monitored semiannually for up to 5.5 years. During follow-up, 224 (35{\%}) HIV-seropositive women and 34 (9{\%}) HIV-seronegative women had incident SILs detected by Pap test; 47 (7{\%}) HIV-seropositive women developed high-grade lesions. The incidence of SILs was 11.5 cases among HIV-seropositive and 2.6 cases among HIV-seronegative women per 100 person-years of observation (rate ratio, 4.5; 95{\%} confidence interval, 3.1-6.4; P <.001). Risk of incident SILs and likelihood of Pap test progression were increased among HIV-seropositive women with CD4+ lymphocyte counts 3 and among women with human papillomavirus (HPV) infection, with risk-ordering from low- to high-risk HPV type. SIL regression was less likely among HIV-seropositive women with higher HIV loads. No beneficial effect of highly active antiretroviral therapy was demonstrated.",
author = "Paula Schuman and Ohmit, {Suzanne E.} and Klein, {Robert S.} and Ann Duerr and Susan Cu-Uvin and Jamieson, {Denise J.} and Jean Anderson and Shah, {Keerti V.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1086/375783",
language = "English (US)",
volume = "188",
pages = "128--136",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Longitudinal study of cervical squamous intraepithelial lesions in human immunodefidency virus (HIV)-seropositive and at-risk HIV-seronegative women

AU - Schuman, Paula

AU - Ohmit, Suzanne E.

AU - Klein, Robert S.

AU - Duerr, Ann

AU - Cu-Uvin, Susan

AU - Jamieson, Denise J.

AU - Anderson, Jean

AU - Shah, Keerti V.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - We examined incidence and correlates of progression and regression of abnormal cervical cytologic test results, defined as at least low-grade squamous intraepithelial lesions (SILs), in 774 human immunodeficiency virus (HIV) - seropositive and 391 HIV-seronegative women monitored semiannually for up to 5.5 years. During follow-up, 224 (35%) HIV-seropositive women and 34 (9%) HIV-seronegative women had incident SILs detected by Pap test; 47 (7%) HIV-seropositive women developed high-grade lesions. The incidence of SILs was 11.5 cases among HIV-seropositive and 2.6 cases among HIV-seronegative women per 100 person-years of observation (rate ratio, 4.5; 95% confidence interval, 3.1-6.4; P <.001). Risk of incident SILs and likelihood of Pap test progression were increased among HIV-seropositive women with CD4+ lymphocyte counts 3 and among women with human papillomavirus (HPV) infection, with risk-ordering from low- to high-risk HPV type. SIL regression was less likely among HIV-seropositive women with higher HIV loads. No beneficial effect of highly active antiretroviral therapy was demonstrated.

AB - We examined incidence and correlates of progression and regression of abnormal cervical cytologic test results, defined as at least low-grade squamous intraepithelial lesions (SILs), in 774 human immunodeficiency virus (HIV) - seropositive and 391 HIV-seronegative women monitored semiannually for up to 5.5 years. During follow-up, 224 (35%) HIV-seropositive women and 34 (9%) HIV-seronegative women had incident SILs detected by Pap test; 47 (7%) HIV-seropositive women developed high-grade lesions. The incidence of SILs was 11.5 cases among HIV-seropositive and 2.6 cases among HIV-seronegative women per 100 person-years of observation (rate ratio, 4.5; 95% confidence interval, 3.1-6.4; P <.001). Risk of incident SILs and likelihood of Pap test progression were increased among HIV-seropositive women with CD4+ lymphocyte counts 3 and among women with human papillomavirus (HPV) infection, with risk-ordering from low- to high-risk HPV type. SIL regression was less likely among HIV-seropositive women with higher HIV loads. No beneficial effect of highly active antiretroviral therapy was demonstrated.

UR - http://www.scopus.com/inward/record.url?scp=0037560095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037560095&partnerID=8YFLogxK

U2 - 10.1086/375783

DO - 10.1086/375783

M3 - Article

C2 - 12825181

AN - SCOPUS:0037560095

VL - 188

SP - 128

EP - 136

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -